94 related articles for article (PubMed ID: 2244575)
1. Effects of intracoronary ergonovine on the contralateral coronary artery in patients with atypical chest pain.
Lambert CR; Theron HD; Pepine CJ
Am J Cardiol; 1990 Dec; 66(19):1383-5. PubMed ID: 2244575
[No Abstract] [Full Text] [Related]
2. Comparison of coronary responses to intracoronary and intraaortic ergonovine and isosorbide dinitrate in patients with atypical chest pain.
Hoshio A; Shirota K; Sawada Y; Fukuki M; Doi T; Kotake H; Mashiba H; Kasahara T; Endo S
Am J Cardiol; 1992 Oct; 70(11):1004-9. PubMed ID: 1414896
[TBL] [Abstract][Full Text] [Related]
3. [The local and systemic effects of intracoronary ergonovine in patients with normal and nonspastic coronary arteries. A comparison with the intravenous ergonovine test].
Fournier JA; Cortacero JA; Hernández Aparicio MC; Granado C; Vallejo J
Rev Esp Cardiol; 1991; 44(6):383-8. PubMed ID: 1924954
[TBL] [Abstract][Full Text] [Related]
4. Gender differences in sensitivity of acetylcholine and ergonovine to coronary spasm provocation test.
Sueda S; Miyoshi T; Sasaki Y; Sakaue T; Habara H; Kohno H
Heart Vessels; 2016 Mar; 31(3):322-9. PubMed ID: 25539623
[TBL] [Abstract][Full Text] [Related]
5. Limited coronary flow reserve after dipyridamole in patients with ergonovine-induced coronary vasoconstriction.
Cannon RO; Schenke WH; Leon MB; Rosing DR; Urqhart J; Epstein SE
Circulation; 1987 Jan; 75(1):163-74. PubMed ID: 3791602
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of adjunctive intracoronary administration of acetylcholine following intravenous infusion of ergonovine to provoke coronary artery spasm.
Goto A; Ito S; Kondo H; Nomura Y; Yasue N; Suzumura H; Takeda Y; Tomimoto S; Yamada Y; Horio T; Suzuki S; Fukutomi T; Itoh M
J Cardiol; 1999 Dec; 34(6):309-16. PubMed ID: 10642927
[TBL] [Abstract][Full Text] [Related]
7. Relationships between more than 90% coronary luminal narrowing induced by ergonovine provocation test and ECG ischemic change as well as chest symptoms.
Sueda S; Kohno H
Heart Vessels; 2018 Feb; 33(2):95-101. PubMed ID: 28808762
[TBL] [Abstract][Full Text] [Related]
8. Coronary reactivity to ergonovine--possible relationship to accelerated coronary arterial disease in cardiac transplant recipients.
Kushwaha S; Lythall D; Maseri A; Mitchell A; Yacoub M
Eur Heart J; 1991 Apr; 12(4):520-5. PubMed ID: 2065686
[TBL] [Abstract][Full Text] [Related]
9. The effect of ergonovine on coronary vasodilatory reserve in patients with angiographically normal coronary arteries.
Tatineni S; Kern MJ; Aguirre F
Am Heart J; 1992 Mar; 123(3):617-20. PubMed ID: 1539513
[TBL] [Abstract][Full Text] [Related]
10. The 24-Month Prognosis of Patients With Positive or Intermediate Results in the Intracoronary Ergonovine Provocation Test.
Shin DI; Baek SH; Her SH; Han SH; Ahn Y; Park KH; Kim DS; Yang TH; Choi DJ; Suh JW; Kwon HM; Lee BK; Gwon HC; Rha SW; Jo SH
JACC Cardiovasc Interv; 2015 Jun; 8(7):914-23. PubMed ID: 26003026
[TBL] [Abstract][Full Text] [Related]
11. The effects of ergonovine maleate on coronary arterial size.
Cipriano PR; Guthaner DF; Orlick AE; Ricci DR; Wexler L; Silverman JF
Circulation; 1979 Jan; 59(1):82-9. PubMed ID: 758127
[TBL] [Abstract][Full Text] [Related]
12. Hypersensitivity of human coronary segments to ergonovine 6 months after injury by coronary angioplasty: a quantitative angiographic study in consecutive patients undergoing single-vessel angioplasty.
Hamon M; Bauters C; McFadden EP; Escudero X; Lablanche JM; Bertrand ME
Eur Heart J; 1996 Jun; 17(6):890-5. PubMed ID: 8781828
[TBL] [Abstract][Full Text] [Related]
13. [Intracoronary administration of ergonovine maleate for detecting vasospastic angina; one dose method].
Ueda O; Okazaki H; Kohchi K; Koga N; Hiraoka M
Kokyu To Junkan; 1991 Jul; 39(7):673-7. PubMed ID: 1896659
[TBL] [Abstract][Full Text] [Related]
14. Effects of intracoronary injection of ergonovine on angiographic normal coronary arteries: study of 108 consecutive patients.
Fournier JA; Cortacero JA; Turá A; Hernández-Aparicio C; Granado C; Vallejo J
Clin Cardiol; 1989 Oct; 12(10):561-8. PubMed ID: 2805461
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcome according to spasm type of single coronary artery provoked by intracoronary ergonovine tests in patients without significant organic stenosis.
Kim DW; Her SH; Ahn Y; Shin DI; Han SH; Kim DS; Choi DJ; Kwon HM; Gwon HC; Jo SH; Rha SW; Baek SH
Int J Cardiol; 2018 Feb; 252():6-12. PubMed ID: 29249438
[TBL] [Abstract][Full Text] [Related]
16. Impact of pharmacological spasm provocation test in patients with a history of syncope.
Sueda S; Kohno H
Heart Vessels; 2018 Feb; 33(2):126-133. PubMed ID: 28905210
[TBL] [Abstract][Full Text] [Related]
17. Ergonovine-induced changes of coronary artery diameter in patients with nonsignificant coronary artery stenosis : relation with lipid profile.
Nedeljkovic MA; Ostojic MC; Beleslin BD; Nedeljkovic I; Milic N; Vukcevic V; Stojkovic S; Saponjski J; Orlic D; Djordjevic-Dikic A; Stepanovic J; Giga V; Petrasinovic Z; Arandjelovic A; Beleslin B; Kanjuh V
Herz; 2007 Jun; 32(4):329-35. PubMed ID: 17607540
[TBL] [Abstract][Full Text] [Related]
18. Effects of neuropeptide Y on coronary artery vasomotion in patients with microvascular angina.
Rosano GMC; Tousoulis D; McFadden E; Clarke J; Davies GJ; Kaski JC
Int J Cardiol; 2017 Jul; 238():123-127. PubMed ID: 28476516
[TBL] [Abstract][Full Text] [Related]
19. Sequential spasm provocation tests might overcome a limitation of the standard spasm provocation tests.
Sueda S; Miyoshi T; Sasaki Y; Sakaue T; Habara H; Kohno H
Coron Artery Dis; 2015 Sep; 26(6):490-4. PubMed ID: 25974266
[TBL] [Abstract][Full Text] [Related]
20. Feasibility and safety of outpatient cardiac catheterization with intracoronary acetylcholine provocation test.
Saito Y; Kitahara H; Shoji T; Tokimasa S; Nakayama T; Sugimoto K; Fujimoto Y; Kobayashi Y
Heart Vessels; 2018 Aug; 33(8):846-852. PubMed ID: 29435640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
